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Dysfunctional cilia underlie a broad range of cellular and tissue phenotypes and can eventually result in the
development of ciliopathies: pathologically diverse diseases that range from clinically mild to highly complex and
severe multi-organ failure syndromes incompatible with neonatal life. Given that virtually all cells of the human
body have the capacity to generate cilia, it is likely that clinical manifestations attributed to ciliary dysfunction will
increase in the years to come. Disputed but nevertheless enigmatic is the notion that at least a subset of tumor
phenotypes fit within the ciliopathy disease spectrum and that cilia loss may be required for tumor progression.
Contending for the centrosome renders ciliation and cell division mutually exclusive; a regulated tipping of balance
promotes either process. The mechanisms involved, however, are complex. If the hypothesis that tumorigenesis
results from dysfunctional cilia is true, then why do the classic ciliopathies only show limited hyperplasia at best?
Although disassembly of the cilium is a prerequisite for cell proliferation, it does not intrinsically drive tumorigenesis
per se. Alternatively, we will explore the emerging evidence suggesting that some tumors depend on ciliary
signaling. After reviewing the structure, genesis and signaling of cilia, the various ciliopathy syndromes and their
genetics, we discuss the current debate of tumorigenesis as a ciliopathy spectrum defect, and describe recent
advances in this fascinating field.
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Ciliogenesis
Once a cell enters quiescence, it must go through a series
of events to realize a fully matured cilium. All cilia sub-
types must conform to a basic structure. The elemental
cilium is composed of the basal body (BB) that is located
at the apical plasma membrane, and an axoneme that
forms a thin projection extending from the membrane
(Figure 1) [1]. The BB is derived from the centrosome and
comprises a mature centriole, accessorized by sub-distal
appendages, connected to an immature centriole that is
surrounded by a dense protein-rich pericentriolar matrix
[2]. In early ciliogenesis, a golgi-derived ciliary vesicle
fuses with the BB at the distal side of the mature centriole
that features the appendages and CEP164 seems to act as
the principal linker between the centriole and ciliary
vesicle [3]. After the basal body has migrated to the* Correspondence: r.giles@umcutrecht.nl
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mediated process [4], the additional structures allow
proper docking at the cell membrane, a complex process
that requires the interplay of at least Ofd1, Ofd2, Ninein,
Mks1, Mks3, Cep164, Poc5 and Cep123, and is extensively
reviewed by Reiter, Blacque and Leroux [5]. Initial invagin-
ation and centriolar elongation of the ciliary vesicle occurs
prior to membrane docking in most cell systems, but can
also occur in later stages. Correct lengthening of the
mature centriole is critical, and is ensured by interplay of
a network of proteins including CP110, CEP97, KIF24 and
TTK2 [6,7]. Once the BB has docked and fused with the
plasma membrane, growth of the axoneme can be initi-
ated, a process fueled by targeting additional vesicles to
the BB. Interestingly, the efficacy of this growth is highly
dependent on the dynamics of local actin filaments [8].
Polarized vesicle transport to the BB is an extremely
complex process and only a few of the proteins/events
required have yet been identified. Firstly, microtubules must
extend from microtubule organizing center and link the
golgi-ER to the basal body, the microtubule- stabilizing andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Structure of the primary cilium. The two centrioles are surrounded by the pericentrosomal matrix, serving as basal body and
microtubule organizing center. Vesicular transport delivers ciliary components either to the basal body or ciliary pocket. Axonemal import is
regulated by the transition zone, which is marked by Y-links. Anterograde kinesin-2- and retrograde dynein-2-mediated IFT sustain ciliary
maintenance and cilia-dependent signaling; the complex rearranges at the ciliary tip.
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tubule minus-end anchoring, defects in which result in
defective cilia biogenesis [9]. BB-targeted vesicles are
covered with coat-proteins for specificity including mem-
bers of the TRAPII, clathrin and exocyst systems (reviewed
by Hsiao, Tuz and Ferland) [10]. Perhaps the best-studied
example of vesicle transport is the BBSome; a protein com-
plex that forms a cilia-specific transport module [11]. An
additional regulatory layer is mediated by Ras-superfamily
GTPases of Rab and Arl/Raf subtypes. These molecular
switches can undergo conformational change upon binding
or hydrolyzing GTP, a process regulated by guanine
exchange factors (GEF) and guanine activating proteins
(GAP). For example, Rab8, Rab11 and the GEF Rabin8
regulate transport of the BBSome [12]. Alternate cilia-
associated vesicle targeting GTPases are Arl3, Arl6 (BBS3)
and Arl13 [10]. Finally, kinesin molecular motors transport
the vesicles. Beyond the well-described kinesin-2 motorcomplex, little is known about other members of the large
and diverse superfamily of kinesins that contribute to
ciliogenesis. Importantly, cilia are highly dynamic structures
requiring a continuous supply of molecules for their main-
tenance [13]. Vesicles can alternatively dock to the ciliary
pocket, a highly specialized endocytic membrane domain
characterized by an invagination of the cell membrane
peripheral to the axoneme [14]. The ciliary pocket is
thought to be a zone of excessive crosstalk between the
ciliary membrane and plasma membrane characterized by
the presence of many endocytosis-associated clathrin-
coated pits [15]. Finally, vesicles could potentially dock to
the ciliary rootlet; a basal body-associated structure that
extends into the cytosol which can at least interact with
kinesin light chain subunits [16].
The transition zone (TZ) is just distal of the mother
centriole and forms a barrier to regulate protein entry
into the cilium [17]. Structurally, the TZ is composed of
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for membrane anchoring and formation of a selectively per-
meable pore (reviewed by Garcia-Gonzales and Rieter [17]).
Size-exclusion prevents large structures from entering the
axoneme [18]. In addition, components of IFT complexes
have been reported to dock to these fibers and possibly par-
ticipate in regulation of ciliary entry [19]. The Y-links are
composed of protein networks, many members of which
are encoded for by classic ciliopathy disease loci (described
below). Located adjacent to the axonemal microtubules is a
core protein complex consisting of NPHP1, NPHP4 and
NPHP8 [20], which interacts with a second core complex
termed the MKS-JBTS module [21]. The MKS-JBTS
module contains distinct proteins, many of which have
lipid-binding domains (C2, B9 domains) including MKS1,
B9D1 and B9D2; these proteins interact with the ciliary
membrane [17]. Anchoring to the membrane requires
transmembrane domain-containing proteins (TMEM), such
as TMEM216 [22] and TMEM237 [23] and interacting
proteins TMEM67 [24], TMEM231 [25] and putatively
TMEM107 [26]. Moreover, SEPT2 forms a diffusion barrier
at the base of the cilium [27]. An emerging aspect of
regulated cilia entry is a proposed import system that is
analogous to and overlaps with the nuclear pore complex.
This so-called ciliary pore complex contains well-known
members of the nuclear pore complex, including Ran-
GTPases, importins and nucleoporins which are known to
localize to the ciliary base [18]. In line with this notion,
some proteins contain ciliary localization sequences, includ-
ing PC1 [28], fibrocystin [29], KIF17 [30], gpr161 [31] and
some myristoylated proteins such as NPHP3 [32].
Nine highly stable axonemal microtubule doublets serve
as major transport fibers for intraflagellar transport (IFT),
an exclusively ciliary transport mechanism that was identi-
fied by pioneering studies of the Rosenbaum lab [33].
Kinesin-2, composed of KIF3A, KAP3 and KIF3B or
KIF3C [34], transports selected cargo and dynein-2 during
anterograde IFT transport towards the ciliary tip. The
complex rearranges at the tip where dynein-2 becomes
activated, facilitating retrograde IFT transport [13]. Both
kinesin-2 and dynein-2 transport a large protein complex
that contains two biochemically and functionally distinct
core sub-complexes termed IFT-A and IFT-B. The IFT-B
complex is composed of 14 members, including the
hallmark IFT88 protein [13]. Dysfunctional IFT-B proteins
typically disturb axonemal growth, indicating that this
complex mainly functions in anterograde transport. In
contrast, the six IFT-A members seem to be mainly
involved in retrograde transport; accordingly, defects in
IFT144 as well as dynein-2 lead to accumulation of IFT
particles at the ciliary tip, generating a bulge [35]. It
should be stressed that this view is a simplification of the
reality; certain members of both complexes are known to
cause inconsistent phenotypes. The core IFT-A, IFT-B,and either kinesin-2 or dynein-2 complexes are thought to
facilitate import across the transition zone as well as
distribution of cargo-proteins along the axoneme [13].
Currently, we are only beginning to understand the full
complexity of achieving specific ciliary import and distri-
bution. Moreover, it is not entirely clear which IFT
components are essential or dispensable for cilia forma-
tion. Finally, once the primary cilium is matured, constant
maintenance is required to render cilia functional. As
protein synthesis is absent in the axoneme, ciliary compo-
nents need to be constantly imported and exported, a
function which is highly dependent, but not exclusively
restricted to the kinesin-2/IFT system [33]. A number of
alternative kinesins appear to have an accessory role in
cilia function. This includes KIF17, the ortholog of
Caenorhabditis elegans OSM-3, a co-factor in axonemal
transport required for distal end formation in a subset of
sensory cilia [34]. While vertebrate KIF17 appears mostly
required for targeting specific ciliary components and for
photoreceptor outer segment function, some results are
contradictory [36,37]. Another kinesin implicated in cilia
function, but not essential for cilia structure or morph-
ology, is the Caenorhabditis elegans gene klp-6, encoding
a kinesin-3 member that transports mechanosensory
polycystins in cilia [38]; however, a mammalian ortholog
has not yet been described. Finally, KIF7 is the mamma-
lian ortholog of Drosophila Costal2, and an important
mediator of sonic hedgehog-signaling in mammals [39].
Although its ciliary transport is pivotal for hedgehog-
signaling, it is neither required for cilia formation nor
stability [39].
Specialized cilia function
Generally speaking, cilia transduce signals from extracellu-
lar stimuli to a cellular response that regulates proliferation,
differentiation, transcription, migration, polarity and tissue
morphology [40]. The textbook example is the renal pri-
mary cilium; a non-motile sensory monocilium extending
from the epithelial apical membrane into the fluid-filled
lumen, easily accessible to extracellular modulators such as
mechanical forces and freely diffusing biological agents.
Similar primary cilia can be found on other epithelia in
organs containing tubular or acinar structures such as the
pancreas [41], and cells of the central nervous system
(CNS) [42]. Cilia expressed in endothelial cells of the
cardiovascular system protrude far less into the lumen and
are implicated in sensing fluid dynamics [43]. Endothelial
cilia appear more submerged in the cell and are character-
ized by the presence of deep ciliary pockets [15], cumulus
cells in developing oocyte structures also exhibit similarly
deep ciliary pockets [14]. More specialized types of cilia,
such as the retinal-connecting cilium and kinocilia together
with actin-based stereocilia, can be found in the visual and
auditory systems. An intriguing recent addition to the
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synapse formed by T-cells towards antigen-presenting cells
which is highly dependent on IFT proteins and therefore
considered a functional homolog of the primary cilium
[44]. Although most cilia subtypes function through
outside-in sensation, some cilia are able to manipulate the
extracellular environment, for example, at the node where
their swirling motion induces fluid flow that subsequently
asymmetrically deposits morphogens to establish body-axis
polarity [45]. Here, cilia motion is achieved through the
orchestrated regulation of dynein arm complexes [45].
The regulation of body-axis polarity is however more
complex and incompletely understood, and depends on the
interplay of centrally placed motile cilia and peripheral
mechanosensory primary cilia that asymmetrically display
an elevated Ca2+ response and corresponding changes in
downstream gene expression [45].
Sperm motility is similarly achieved through swirling
motion, but these cilia (or flagella) can also display a
whip-like beating pattern, attributable to an additional
central pair of microtubules. Finally, beating cilia can also
be found in ependymal cells, fallopian tube epithelia and
epididymis epithelia, generating fluid flow, or, in the tra-
chea, stimulating mucus transport [1]. Despite this large
diversity, when pan-ciliary processes are disturbed, multi-
organ pathologies arise that are collectively termed
‘ciliopathies’ [46].
Ciliopathies
In their landmark paper, Pazour and colleagues [47]
describe the IFT core component Ift88 to be essential in
Chlamydomonas reinhardtii and mouse primary cilia
formation, thereby kicking off more than a decade of
research that has highlighted the importance of cilia
function in development and tissue homeostasis. Given
the broad expression and function attributed to cilia [48]
it is not surprising that defects in this organelle gives rise
to a multitude of organ-specific functional defects and
pathologies, most of which are prominent in a number of
pleiotropic disease-syndromes.
There are many phenotypes that regularly associate with
ciliopathies. Common ciliopathy disease syndromes are
Bardet-Biedl syndrome (BBS), Jeune asphyxiating thoracic
syndrome (JATD), orofaciodigital syndromes (OFD),
nephronophthisis (NPHP), Meckel syndrome (MKS),
Senior-Løken syndrome (SNLS), Sensenbrenner, Joubert
syndrome (JBTS) Alström syndrome (ALSM), Usher syn-
drome (USH), Leber congenital amaurosis (LCA), short-
rib polydactyly syndromes (SRPS) and Ellis van Creveld
syndrome (EVC) [46,49]. Most notably affected is the
kidney, which features the development of renal cystic ex-
pansion that is comparable to lesions caused by autosomal
dominant and recessive forms of polycystic kidney disease
(ADPKD, ARPKD) [50], coupled with degeneration andincreased fibrosis in the case of nephronophthisis [49].
Cyst formation can also often be observed in the pancreas
and liver [51]. Other frequently observed disease manifes-
tations are retinal and auditory defects such as retinitis
pigmentosa (RP), retinal dystrophy and sensorineural
hearing loss [46]. Severe ciliopathies are characterized by
abnormal bone development that can be apparent as short
ribs and shortening of the long bones, polydactyly and
severe craniofacial malformations [52]. Somewhat overlap-
ping with the craniofacial phenotypes are CNS defects,
including encephalocoele, hydrocephalus and cerebellar
abnormalities such as corpus callosum aging and cerebel-
lar vermis hypoplasia [46,53]. The capacity of the brain to
interpret the senses is often affected in ciliopathies,
resulting in neurological disorders; cognitive impairment,
anosmia, mental retardation, autism, and obesity are
apparent in various degrees in many of the ciliopathies
[53]. In line with this hypothesis is the recent study testing
genes implicated in the neuropsychiatric disorders
schizophrenia, bipolar affective disorder, autism spectrum
disorder and intellectual disability; the authors identi-
fied 20/41 genes to reduce and 3/41 to increase cilia
length [54].
A unique category of ciliopathies is associated with
motile cilia dysfunction in primary ciliary dyskinesia (PCD)
or Kartagener’s syndrome. Here, primary cilia function
without apparent defects, but motile cilia are affected.
Failure to generate ciliary motion can cause situs inversus
(only associated with Kartagener’s syndrome), infertility due
to immotile spermatozoa and recurrent airway diseases
resulting from suboptimal mucus clearance from the
trachea and lungs and subsequent extended exposure to
pathogens. Clinical symptoms include chronic otitis media,
rhinitis, nasal congestion, sinusitis and bronchiectasis [55].
Large-scale genetic, proteomic, and genotype-phenotype
studies have generated an ever-growing list of crucial
ciliary mediators. Roughly 1,000 proteins comprise the
ciliome, calculated from a combination of proteomics and
comparative genomics [56]. There is significant pleiotropy
in the various ciliopathy syndromes, as well as a gradual
increase in severity of disease, indicating that some cilia
processes are only slightly modified, whereas others
severely impaired. To date, mutations have been recovered
at > 50 ciliopathy disease loci, but novel loci are recovered
at a high rate. For extensive reviews on the clinical
pathologies and genetics associated with ciliopathies we
recommend excellent recent reviews by Tobin and Beales
[46], Waters and Beales [49], D’Angelo and Franca [51]
and Davis and Katsanis [57].
Ciliary signaling
The cilium protrudes into the extracellular environ-
ment, rendering it susceptible to outside-inside-signaling
excited by extracellular cues including flow (kinetic) and
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The cilium forms a semi-closed system requiring regu-
lated import, retention, and export of components [17]
which allows a controlled regulation of signaling mole-
cules passing through the cilium. In recent years, a
number of core signaling pathways have been described to
depend on intact cilia.
Physical sensation of flow, pressure, touch and vibration
is referred to as mechanosensation. Although cilia are
flexible, there is a basal level of rigidity provided by the
axonemal microtubule network. Much of our understand-
ing of mechanosensory mechanisms associated with cilia
were derived from studies of renal tubules that are lined
with ciliated epithelial cells, where the force of luminal fluid
flow determines the direction and bending of the cilium
(Figure 2A) [58]. The polycystin proteins PC1 and PC2
(encoded for by PKD1 and PKD2 genes which when mu-
tated cause ADPKD) play a key role in mechanosensation
and heterodimerize into an ion channel-complex [58].Figure 2 Ciliary signaling. (A) Mechanosensation. Flow induces cilia bend
intracellular Ca2+ levels that acts as a second messenger. In PKD, the polycys
is perturbed, leading to inappropriate responses and eventually cyst formati
with and without Hh-ligand present. Abnormal Hh-signaling in the absenceThe causal gene for the related pathology ARPKD,
the PKHD1 gene encoding fibrocystin, is associated with
the polycystin complex [59]. Upon shear stress, the
polycystin complex opens and imports extracellular
Ca2+, elevating the intracellular Ca2+ concentration. Subse-
quently, modulated intracellular Ca2+ levels can act as a
general second messenger to affect multiple downstream
processes. Next to its role in mechanosensation, PC1 can
additionally act as a transcriptional activator. In the
presence of flow, PC1 is normally sequestered to the cilium;
when flow is ceased, protealytically cleaved PC1 can,
together with STAT6 and p100, activate a transcriptional
program [60]. The relevance of polycystin function in
adult tissue appears overall less dramatic compared to
developmental stages, showing rather mild renal failure
compared to the acute development of large cysts respect-
ively [61].
The complexity of Ca2+ as a second messenger is
complicated by excessive cross-talk between down-ing, the polycystin complex is a Ca2+ channel and causes an increase of
tin complex fails to elevate intracellular Ca2+ hence mechanosensation
on. (B) Schematic representation of Hh-signaling in normal conditions
of primary cilia or in retrograde dynein-2 mutants.
Basten and Giles Cilia 2013, 2:6 Page 6 of 23
http://www.ciliajournal.com/content/2/1/6stream targets and the large number of potentially
affected targets. One important pathway downstream of
mechanosensation-induced Ca2+-signaling is the Wnt-
pathway. In unperturbed renal epithelial cells, for
example, increased Ca2+ promotes the non-canonical
over canonical signaling, whereas in various cilia-
defective cells, an upregulation of canonical Wnt-
signaling is noted [62]. The Wnt-signaling pathway is
discussed in more detail below.
In other cell types, including sensory neurons, cilia
bending also results in modified cAMP- signaling which
can ultimately activate MAP/ERK-signaling and down-
stream proliferation [63]. In PKD, reduced intracellular
Ca2+ concentration results in decreased phosphodiesterase
1-mediated conversion of cAMP to AMP, with consequent
amplification of cAMP-signaling and downstream MAP/
ERK target activation [62]. In turn, deregulation of the
TSC1/2-mTOR pathway by cAMP/MAPK also associates
with PKD; however the direct role of Ca2+ in mTOR-
signaling has not been properly studied. For detailed
reviews on cilia/Ca2+- signaling in the developments of
renal cysts, we refer to comprehensive reviews by Abdul-
Majeed and Nauli [62] and Kotsis, Boehlke and Kuehn
[64]. Other regulators of mechanosensation, physical
conditions such as osmotic pressure, heat shock, touch
and extracellular matrix movements or vibrations can also
excite ciliary-signaling and the mechanisms involved are
slowly emerging [65,66].
Hedgehog (Hh)-signaling largely depends on cilia integ-
rity. It was noted that inhibition of ciliogenesis in mouse
knockout models of kif3a or ift88 showed phenotypic
overlap with mutant members of the hedgehog-signaling
pathway [1]. Hh-signaling is implicated in many diverse
(embryonic) developmental processes and includes regula-
tion of tissue patterning and cellular differentiation, prolif-
eration and survival [67]. Hh-signaling can be initiated by
three ligands; sonic-Hh (Shh), Indian-Hh (Ihh) and
Desert-Hh [68], the summarized mechanism described
below is based on the best characterized member Shh.
Although the exact mechanisms are not fully elucidated
and there appears to be tissue-specificity, there is a basic
understanding of how the pathway acts through the
cilium (Figure 2B). In the absence of Hh-ligand, the
hedgehog ligand binding receptor Patched (Ptc) localizes
to the cilium and through an unknown mechanism
Smoothened (Smo) is mostly retained in vesicles and
excluded from localizing to the plasma membrane and
entering the cilium [69], although a basal level is thought
to traffic through cilia as well [70]. There are three
mammalian paralogs of the Glioma family described; Gli1,
a transcriptional activator that is upregulated after initial
pathway activation, Gli2, the principal transcriptional acti-
vator and Gli3, the principal transcriptional repressor [71].
In the absence of Hh-ligand, Gli2 and Gli3 are complexedwith the negative regulator Sufu and Kif7, which serves as
a scaffold for PKA, GSK3β and CK1, promoting a cullin3/
ubiquitin proteasomal-mediated cleavage that generates
the Gli2R and Gli3R repressor forms, allowing the GliR’s
to translocate to the nucleus and repress transcription
[72]. In the presence of Hh-ligand, Ptc is excluded from
the cilium and Smo becomes activated and translocates to
the ciliary membrane, facilitated by β-arrestin and Kif3a
and possibly other factors [71]. Simultaneously, Kif7, Sufu,
Gli2 and Gli3 transition to the ciliary tip and the Sufu
interaction is lost, allowing Gli2A and Gli3A stabilization.
How Smo exactly activates GliA is not fully elucidated,
but ciliary Smo is required for GliA formation, and
probably does so by antagonizing Sufu. Although GliR
regulation by Sufu does not require the presence of cilia
[73], efficient formation of the repressor forms does not
occur in cells without cilia [74]. Upon activation, GliA is
dependent on retrograde IFT (dynein mediated) to exit
the cilium after which it translocates to the nucleus to
drive the expression of target genes. Defects in cilia integ-
rity therefore modulate Hh-signaling, and depending on
the underlying defect, either activate or dampen Hh-
signaling [69]. Developmental processes that depend on
hedgehog activity, such as neural tube patterning, are
affected by defects in the pathway activation as is observed
in cilia-deficient cells that fail to generate GliA. Alterna-
tively, limb development requires efficient GliR formation,
which is also perturbed in cilia-deficient cells [69]. Kif3a
mutants, most IFT-B complex mutant alleles that perturb
cilia formation (IFT52, 57, 88, 172), as well as other inhibi-
tors of cilia formation such as TTK2, result in a constitu-
tive dampening of the Shh pathway, as cilia are required
for proper GliA and GliR processing [7,75,76]. Defects in
the dynein-2 motor impede retrograde transport leading
to an accumulation of proteins at the ciliary tip; conse-
quently the membrane at the ciliary tip expands to form a
bulge [77]. Dynein-2 mutations also impair Hh-activation
due to the inability of GliA to translocate to the nucleus.
Mutations affecting IFT-A complex members IFT139/
TTC21B and IFT122, which primarily regulate retrograde
axonemal transport, hyperactivate the pathway [78,79]. In
contrast, other IFT-A mutants (IFT121, IFT144) display
similar effects to IFT-B mutants, indicating that these are
required for cilia formation, possibly reflecting the com-
plexity of interplay between IFT-A members in transport
of membrane proteins like Smo and ACIII [35]. For an
extensive description of the relation between cilia and Hh-
signaling, we recommend reviews by Goetz and Anderson
[69] and Robbins et al. [71].
Both canonical and non-canonical Wnt-signaling regu-
late developmental and homeostatic processes [80]. The
cilium seems to play a role in dictating the outcome of
Wnt-ligand binding towards either pathway, but the
details are not fully understood and data occasionally
Basten and Giles Cilia 2013, 2:6 Page 7 of 23
http://www.ciliajournal.com/content/2/1/6conflict. Put simplistically, in the absence of canonical
Wnt-signaling, β-catenin is caught in a destruction
complex together with Axin, adenomatous polyposis coli
(APC), casein kinase 1 (CK1) and glycogen synthase
kinase 3β (GSK3β) [80]. Wnt-ligand binding to the
transmembrane receptors frizzled (Fz) and low density
lipoprotein receptor-related protein 5/6 (LRP5/6), recruits
dishevelled (Dvl) and Axin, resulting in disassembly of the
destruction complex and subsequent accumulation of
β-catenin in the nucleus, where it regulates transcription
factors [80]. One body of evidence suggests a role for cilia
in restraining canonical Wnt (Figure 3A). Downregulation
of essential ciliogenesis genes BBS1, BBS4, MKKS or
KIF3A in HEK293T cells and zebrafish embryos [81] as
well as Kif3a, Ift88, Ofd1 in murine cells [82] lead to
nuclear β-catenin accumulation and enhanced transcrip-
tional activity of canonical Wnt target genes. Similarly,
genetic mutant Chibby mice [83] as well as zebrafish mu-
tant for the seahorse allele [84], encoding cilia-associated
(Chibby) and related (Seahorse) proteins, result in canon-
ical Wnt activation. The nephronophthisis protein
NPHP2/INVS normally recruits Dvl, thereby renderingFigure 3 Canonical and non-canonical/PCP-signaling and cilia. (A) Can
dampen Wnt-signaling; DVL is recruited by INVS/NPHP2 to the cilium, norm
signaling off, Jouberin (Jbn) sequesters a pool of β-catenin and recruits it t
recruit DVL, which translocates to the membrane and activates Wnt-signali
and β-catenin potentiate Wnt-signaling as a larger pool can translocate to
in a polycystic kidney. Disturbed PCP affects the orientation of cell divisionβ-catenin in the destruction complex; disruption of INVS
allows Dvl to translocate to the membrane potentiating
nuclear β-catenin accumulation [85,86]. Furthermore,
nuclear β-catenin is a common hallmark of renal cysts,
and oncogenic β-catenin is sufficient to drive cytogenesis
[87]. The JBTS protein Jouberin/AHI1 also seems to
inhibit canonical β-catenin-signaling via sequestration to
the primary cilium; AHI1 regulates both β-catenin nuclear
import and ciliary localization. Defects in cilia formation
potentiate Wnt responsiveness, and tethering β-catenin to
the cilium reduces canonical Wnt-signaling [88]. In line
with this notion, Ahi mutant mice do not show nuclear
β-catenin accumulation and signaling in their kidney
cysts, which also raises the question of how relevant
canonical Wnt-signaling is for renal cyst development
[89]. Several other studies similarly contradict the activa-
tion of Wnt-signaling solely due to cilia disruption; Ift88,
Ift172 and Kif3a mutant mouse embryos and maternal-
zygotic zebrafish ift88 mutants do not show altered
canonical Wnt-signaling [90,91], suggesting that results
reflect tissue and developmental stage-specific discrepan-
cies [69]. Another study indicated that altered Wnt-onical Wnt-signaling. When cilia are present, multiple mechanisms
al flow sensation elevates intracellular Ca2+ levels that switch Wnt-
o the ciliary compartment. In cilia mutants, mislocalized INVS fails to
ng. Ca2+ response is lost, which fails to switch Wnt-signaling off. Jbn
the nucleus. (B) Illustrative model of cystic expansion of a renal tubule
within the plane of tissue organization.
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[92]. Importantly, Ca2+ levels can also affect the canon-
ical Wnt pathway [93], and Ca2+ influx as a result of
mechanosensation is proposed to switch canonical Wnt
off, whilst turning non-canonical signaling on [94]. The
absence of proper flow-sensing in organs with dysfunc-
tional cilia impairs Ca2+-mediated Wnt regulation which
further complicates dissection of the various pathogenic
pathways. Likely Wnt regulation occurs through various
mechanisms, even in close proximity to the cilium and
basal body and the effect of cilia towards canonical Wnt-
signaling is subtle, dependent on cell type and develop-
mental stage. Generally, defects associated with defective
cilia/β-catenin-signaling appear less severe compared to
Hh- mediated-signaling [95].
In the non-canonical pathway, β-catenin is dispensable
and Wnt-signals act under control of planar cell polarity
(PCP), but again there are conflicting data on the direct
role of cilia in PCP-signaling. PCP regulates the correct
expansion and homeostasis of polarized tissue (Figure 3B)
and it is evident that many ciliopathies feature PCP
defects; for example, the cystic phenotypes are likely a
defect of altered PCP [50]. Convergent extension during
gastrulation in development is a PCP-mediated process,
and defects in cilia genes such as INVS, BBS1, BBS4,
BBS8, MKKS and OFD1 induce convergent extension
defects [95]. These data collectively point to the hypoth-
esis that cilia are involved in the switch between canonical
and non-canonical Wnt-signaling, which is independent
of the PCP-signaling pathway [95]. A developing view in
the field is that cilia are not extensively involved in
regulation of polarity proteins through deregulating PCP-
signaling, but that this defective polarity is the result of
mis-positioning of the centrosome during cell division
[95]. Indeed, many ciliopathy proteins such as IFT88,
OFD1 and BBS4 are essential for proper centrosome
composition and structural stabilization [96-98]. PCP-
signaling itself can affect correct basal body docking and
ciliogenesis [99]. Studies in mammalian cells are sparse
however, and most knowledge has been obtained from
Drosophila and Xenopus studies. Essential PCP- signaling
molecules that affect ciliogenesis include Fuzzy, Inturned,
Fritz and Dvl. The molecular role for these proteins is
emerging and it is suggested they affect processes includ-
ing actin remodeling and ciliary-vesicle transport [95]. For
a more extensive discussion about the relation between
cilia, Wnt-signaling and PCP we recommend a review by
Wallingford [95].
Platelet-derived growth factor (PDGF)-signaling affects
cell migration, proliferation and survival [100]. Upon cell
cycle exit, the receptor PDGFRα is upregulated and
localizes to primary cilia in cultured fibroblasts [101].
Binding of the ligand PDGF-AA activates the dimerized
PDGFRαα receptor and downstream Akt, ERK1/2- andMEK1/2-signaling molecules [101]. Defects in primary
cilia formation disrupts PDGF-AA-signaling and affects
endothelial cell function [102]. The PDGF receptor is a
receptor tyrosine kinase (RTK); recently other RTK-
signaling events were described as being mediated
through primary cilia in some cell culture models, includ-
ing epidermal growth factor receptor (EGFR), insulin-like
growth factor (IGF1R), and the angiopoietin receptor
(Tie-2), For a detailed description of the implications
RTK-signaling might have in light of cilia sensing, we refer
to a recent review by Christensen, Clement, Satir and
Pedersen [103]. Fibroblast growth factor (FGF)- signaling
has been shown to affect cilia length and affect left-right
determination, a process dependent on proper cilia
functioning [104].
Hippo-signaling (Salvador-Warts-Hippo) has recently
been added to the growing list of signaling pathways at
least partly regulated through the cilium. Hippo-signaling
is based on a number of serine/threonine-kinases that are
involved in controlling organ size and cell proliferation.
Many members act as tumor suppressor proteins as well
as proto-oncogenes [105]. NPHP4 interacts with the
Hippo regulator LATS, allowing the transcription factors
YAP and TAZ to translocate to the nucleus. In the
absence of NPHP4, Hippo-signaling is overactive and cell
proliferation is limited. NPHP4 may regulate the renal
fibrosis associated with most ciliopathies through CTGF
transcriptional regulation [106]. The Crumbs receptor
family is known to affect Hippo-signaling [107] and
Crumb3 has been shown to localize to the cilium [108].
Furthermore, Hippo pathway core component Mob1 delays
ciliogenesis in Tetrahymena [109]. Histological examination
of human PKD sections demonstrates nuclear translocation
of YAP and TAZ [110], and deregulated Hippo-signaling
itself can result in cyst formation, possibly through cross-
talk between Hippo- and canonical and non-canonical
Wnt-signaling [94].
Apart from these core-signaling pathways receiving
much attention in the past years, new developments have
expanded the list of cilia-related-signaling. In endothelial
cells, endothelial to mesenchymal differentiation depends
on cilia function towards TGFβ activity [111]. In skin
development, cilia are required for proper Notch-signaling
and progenitor cell differentiation [112]. Tubby proteins
were recently shown to serve a bridging function between
specific membrane domains and IFT, affecting signaling
[113], and alterations of cilia membrane composition itself
are sufficient to disrupt signaling [114,115]. The coming
years will likely show an upsurge of signaling modulation
regulated by the primary cilium.
Reciprocal regulation of cilia and the cell cycle
The eukaryotic cell cycle dictates and regulates cellular
duplication, and recognizes five consecutive but distinct
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The G1 centrosome has one mature or mother centriole
that is equipped with distal appendages and one incom-
plete daughter centriole. Once cells are properly stimu-
lated by mitogenic or growth factors they prepare for
entry into S-phase, and towards the end of G1-phase the
daughter centriole matures to a full-length centriole.
When cells enter S-phase, the chromosomes and the
centrosome are duplicated and both centrioles serve as a
platform to assemble two new incomplete centrioles;
master regulators driving centrosome duplication include
PLK4 and SAS6 [116]. Following S-phase, cells enter G2
to prepare for the physical chromosome partition; the
initial mother and daughter centrioles together with the
newly formed pro-centrioles separate and migrate to
opposing sides. After nuclear envelope breakdown and
chromosome condensation, the centrosomes become a
regulatory center for bipolar spindle formation that
connects microtubules to the chromosomes. During
metaphase, all chromosome pairs must be connected to
either centrosome and congress to the metaphase plate.
Once the spindle assembly checkpoint is inactivated cells
proceed into anaphase, the duplicated chromosomes are
disengaged and exactly one copy of each moves apart
towards the centrosome. The site of the metaphase plane
now becomes a site where the membrane is progressively
invaginated. The remaining microtubules allow membrane
vesicles to accumulate and deposit membrane and other
essential components of the cytokinetic machinery. When
the remaining cleavage furrow is broken, cells pinch off
from each other and return to G1. During late G2/M, the
daughter centriole has matured to a mother centriole with
the addition of distal appendages. After cell division, each
cell contains one new centrosome composed of either a
grandmother or mother centriole and both contain one
incomplete daughter centriole [116]. Most cells in the
human body will enter the G0 or quiescent stage after
successful cell division (Figure 4). Because the centrosome
is involved in both cell division and ciliogenesis, these
processes are mutually exclusive and there is a continuous
tipping of balance to recruit the centrosome for either
process. Upon entrance into G0, the mother centrioles
have the unique capacity to dock to the cell membrane
and initiate axonemal growth, as discussed above. An
exception to the rule are multiciliated cells; in these
terminally-differentiated cells, centrosomes must be
assembled de novo and one cell can form up to hundreds
of centrosomes, each having the capacity to form a
cilium [116].
A number of proteins intimately associated with
ciliogenesis and cilia function are additionally implicated
in cell cycle control, which can be achieved by functioning
within any of the numerous essential cell cycle processes
described above. We will first discuss the cell cycle defectsobserved for a number of cilia proteins that can result in
alterations in cell cycle timing and the fidelity of centro-
some duplication, chromosome segregation and cytokin-
esis. Microtubule-anchoring to the centrosome requires
functional BBS4, which interacts with the microtubule
network organizer PCM1. Knockdown of BBS4 in cell
culture blocks cell division progression and induces an
increase in apoptosis [98]. Bbs4 knockout mice similarly
show disorganized microtubules in dendrites, but no se-
vere apoptosis was described, suggesting tissue-specificity
of the BBS4/PCM1 interaction and redundancy in vivo
[117]. A similar mouse knockout phenotype [118] and
defect in cytokinesis has been shown for MKKS/BBS6
upon cell culture knockdown, however in contrast to the
BBS4 phenotype, no defects in microtubule organization
were observed; the authors suggested that the chaperonin
activity of BBS6 might be required for a cytokinetic-
specific process [119]. IFT88 overexpression in non-
ciliated cells blocks G1/S transition and depletion induces
cell cycle progression [120]. IFT88 interacts with the Rb
inhibitor Che-1, suggesting a model in which IFT88 deple-
tion allows Rb to become active and induce cell cycle
progression independent of a microtubule and dynein
interaction [120]. The ORPK/Ift88 mouse mutant accord-
ingly displays epithelial cell hyperproliferation in several
tissues [121,122], but it remains undetermined if this
directly attributable to the IFT88/Che-1 interaction, as
ciliary- signaling through Wnt, for example, is also modi-
fied. Another IFT-B complex member, IFT27, delays cell
cycle progression upon knockdown in Chlamydomonas
reinhardtii and affects cytokinesis [123]. Apart from
associating with the IFT-B complex, stoichiometric data
suggests about half of the IFT27 protein does not interact
with this complex. Given that IFT27 is a Rab-like G-
protein, it has been suggested that IFT27 might have a
transport function from the centrosome to cleavage
furrow during cytokinesis [123]. Interestingly, knockdown
of IFT27 also resulted in reduced expression of other IFT
members, including IFT46, IFT52, IFT81 and IFT139.
Another study showed that the IFT27 and IFT46 are
dynamically regulated during the Chlamydomonas cell
cycle, peaking during the S-M cell division phases, indicat-
ing that transcriptional control of these IFT members is
restricted within the cell cycle [124]. Furthermore, IFT27,
IFT46, IFT72, IFT139 relocalize to the cleavage furrow
during cytokinesis [124]. Together with the notion that
IFT proteins play roles in non-flagellar transport, such as
during the formation of the immunological synapse in T-
cells [44], it could now be suggested that some IFT
components play general roles in membrane transport,
not limited to IFT [124]. This is further supported by the
evolutionary origins of core IFT members that share
homology to other transport coat complexes such as
COPI [125]. This notion is supported by another study
Figure 4 Cilia length in control of cell cycle progression. Cilia provide a physical block for cell cycle progression by laying claim to the basal
body. Disassembly of the primary cilium is required to liberate the centrosome and allow duplication during S-phase and subsequent formation
of the mitotic spindle during chromosomal segregation. Cilia mutants that inhibit ciliogenesis are prone to initiate rapid cell duplication when
properly stimulated, and in contrast, increased axonemal length delays cell cycle progression. The maturation steps (growth and appendages) of
the centrioles are indicated during the various cell cycle stages.
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regulate cytokinesis and ciliation by comparative proteo-
mics and was more extensively shown for PRC1, MKLP-1,
INCENP and centriolin in Caenorhabditis elegans and cell
culture studies [126].
One proposed explanation for the cell cycle defects
observed is that the balance between centrosome and basal
body transition is disturbed, leading to cell cycle checkpoint
activation [127]. This seems to be accompanied by activa-
tion of key regulators of the G1/S transition, Cdk2 and
cyclin E, when centrosomes are disengaged from ciliation
[127]. Alternatively, proteins that are required for centro-
some biogenesis and whose absence leads to structural
defects, induce a p38/p53/p21-dependent checkpoint acti-
vation [128]. Overall, evidence is accumulating that a
number of components initially linked to the cilium have
functions that are not limited to the cilium alone, but have
retained or acquired properties that render them essential
to alternative cellular processes. These could either be
through evolutionary conservation and a specificity that is
less stringent towards the cilium than expected or dual
functions of a particular protein.
The mechanisms controlling ciliogenesis are discussed
in more detail above, but one of the first prerequisite is
the absence of proliferative stimuli; in vitro, most cell lines
require serum deprivation to enter G0 and initiate
ciliogenesis. Another factor is ascertaining established
polarity. Inversely, there are also mechanisms controlling
ciliary disassembly, which are incompletely understood.
Depending on the cell type, disassembly occurs in S-phase
or before the G2/M transition [129], and is known to be
initiated in two waves [130]. The best-studied disassembly
mechanism involves the Aurora A kinase, which can be
activated by the scaffolding protein HEF1/NEDD9. AuroraA in turn activates the tubulin deacetylase HDAC6, hence
destabilizing axonemal microtubules and initiating cilia
resorption [130]. Pitchfork/PIFO localizes to vesicles and
the basal body and it can similarly activate Aurora A
through direct interaction. Reducing PIFO in murine
embryos generates mitotically arrested cells with ciliated
spindles, whereas overexpression generates centrosomal
overduplication [131]. Alternatively, HEF1 can be acti-
vated by canonical Wnt-signaling components Wnt3a,
Dvl2 and β-catenin [132]. In addition, activation of the
non-canonical Wnt pathway through Wnt5a and casein
kinase-1-epsilon-induced complex formation of Dvl2 and
Plk1, that stabilizes HEF1 and allows Aurora A activation
to induce cilia disassembly [133]. The never in mitosis A
(NimA) related kinase NEK2 is another important
mediator essential for cilia resorption at the G2/M transi-
tion, but the exact mechanisms involved and a connection
to the Aurora A pathway are uncertain [134]. In contrast
to controlling timely resorption of cilia, other networks of
centriolar proteins prevent aberrant cilia assembly. CP110
localizes to the distal end of centrioles where it interacts
with, and prevents, NPHP6 and Rab8a from initiating
ciliogenesis [135]. A distinct complex of CP110 and
CEP97 also prevents cilia assembly [136]. In quiescent
cells, both KIF24 and its interaction partners CP110 and
CEP97 are removed from the mother centriole distal end
to promote ciliogenesis [6]. KIF24 depolymerizes
centriolar microtubules to prevent premature cilia assem-
bly, and loss of KIF24 promotes ciliogenesis even in
cycling cells [6]. The recently described protein TTBK2
promotes the removal of CP110 to allow for cilia forma-
tion [7]. Furthermore, a CP110/Centrin/CaM module
regulates cytokinesis [137], indicating a broad functional
spectrum for CP110. The complex interplay of regulators
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road of basal body and centrosome.
It is becoming clear that the axonemal length directly
influences cell cycle time (Figure 4) and reduction of cilia
length or cilia depletion allows cells to enter S-phase more
rapidly. Mutations in INPP5E (also called JBTS1) disrupt
the balance of phosphoinositides which makes cells more
prone to re-enter the cell cycle upon growth factor stimula-
tion; functional in vitro studies suggest the cilium can
dampen the response to mitogenic cues and prevent
premature cell cycle entry [114,115]. INPP5E interacting
proteins CEP164, ARL13B and PDE6 are required for
INPP5E targeting to the cilium with depletion of these fac-
tors associating with the severe JBTS and MKS ciliopathy
syndromes [138]. Inversely, increased cilia length can delay
cell cycle re-entry. Recently, it became evident that Nde1
and Tctex1 regulation of dynein subunits affects cell cycle
progression [139]. Nde1, which is normally expressed at
low levels in quiescence, recruits axonemal dynein complex
member LC8 and subsequent cilia length suppression.
Depletion of Nde1 results in increased ciliary length,
thereby delaying cell cycle progression [140]. Tctex1 associ-
ates with the cytoplasmic dynein complex, but upon activa-
tion relocates to the basal body where it promotes ciliary
disassembly and cell cycle progression [141]. Previously
identified factors that increase cilia length are male associ-
ated germ-cell kinase (MAK) and cell cycle-related kinase
(CCRK) [13]. TSC1 and TSC2 similarly increase cilia length
in response to energy/nutrient sensing (discussed further
below). Intracellular levels of second messengers also influ-
ence cilia length; lowering Ca2+ and elevating cAMP levels
increases cilia length. Under flow conditions, intracellular
Ca2+ levels rise again and cAMP decreases, reducing cilia
length [142]. Phosphatase inhibitor-2 (I-2) is necessary for
microtubule acetylation and thus stability, and is located on
the membrane in proximity to the docked basal body. In-
hibition or deletion of I-2 reduces cilia length [143]. Several
ciliopathy syndromes are associated with neurological
disorders, suggesting that cilia might be involved in the de-
velopment of these diseases. A recent RNA interference
screen in NIH3T3 cells, targeting selected genes that were
previously identified in genome-wide association studies for
neurological disorders, indeed appeared to affect cilia
length negatively. In contrast, three targets significantly
enhanced cilia length; CCDC18, FOXP1 and MIR137,
although the underlying mechanism was not determined
[54]. Also, G-protein coupled receptors are frequently
located to primary cilia, such as serotonin and somato-
statin, as well as the recently described shh antagonist
Gpr161 [31]. Some G-protein coupled receptors affect cilia
length; activation of dopamine D5 receptor increases cilia
length [144], as does dopamine receptor D1 [145]. Modifi-
cation of cilia length might also be important for signal
interpretation, for example in the CNS.Cilia and cancer
Because cilia have the ability to physically influence the
cell cycle and manipulate signaling cascades, it has been a
long-running hypothesis that defective cilia biogenesis
could be an important step in cancer development.
However, much of the data in this arena rests on in vitro
studies and it thus remains to be established how, and if,
there is a direct relationship between ciliary dysfunction
and tumorigenesis. One of the major arguments against a
direct role of cilia in tumorigenesis is the lack of evident
tumor predisposition in patients with many classic
ciliopathies such as SLNS, LCA and NPHP. However,
mortality from organ function impairment may mask true
tumor incidence in ciliopathy patients. The JBTS disease
gene JBN/AHI1 sensitizes tissue for Wnt activation,
allowing low Wnt levels to improperly activate cells and
induce over-proliferation. Accordingly, oral hamartomas
have been associated with Joubert Syndrome-related
disorders [146,147]. There is some conflicting data on the
risk of heterozygote relatives of BBS patients to develop
renal cancer; one small study recognized a 17-fold
increase risk [148], but a larger study disputed this finding
in their cohort [149]. To date though, with the exception
of a few case reports, cancer has not been reported to
associate systemically with the relatives of these recessive
ciliopathies. Heterozygous carriers therefore do not seem
to be at increased risk for cancer development, but it will
be important to closely monitor these carriers in respect
to tumor development and determine putative biallelic
inactivation. Impaired cilia function can induce inappro-
priate responses in progenitor cells, expanding the stem
cell compartment or differentiate into dysplastic tissue, as
is observed in the epidermis, vascular system and
mammary gland [111,112,150]. Alternatively, it is becom-
ing evident that many proteins encoded for by familial
cancer genes do actually affect cilia function. The cilium is
an important mediator of homeostasis and a growing
number of proteins which affect both cell ciliation and
tumorigenesis have been identified.
Clinical observations of cilia and cancer
As most tissues in the human body at least have the
capacity to express cilia, it is important to address the
effect on cilia expression in corresponding tumor types.
Currently this is still an understudied field, and only a
small number of tumor types have been subjected to
detailed cilia analysis [151]. In breast cancer development
there is little information on cilia involvement available,
however, the cilia-associated genes Gli1 (Hh effector),
RPGRIP1 (LCA) and DNAH9 (PCD) are commonly
mutated in breast cancer [152,153]. A later study indicated
that ciliary frequencies are decreased in breast cancer
tissue and breast cancer-derived cell lines when compared
to normal breast tissue fibroblast and epithelia; cilia
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severely reduced in cell lines derived from aggressive
cancer lines, furthermore this was shown to be independ-
ent of increased proliferation through determining the
number of Ki67 positive cells [154]. Accordingly, analysis
of murine mammary glands indicates that cilia are
expressed during development and remain present on
myoepithelial and stromal cells but are absent from
luminal epithelia in matured mammary glands [155].
Detailed analysis of Hh-signaling and primary cilia in
mammary basal cell hyperplasia characterizes the Hh-
responsive cells as progenitor-derived cells bearing cilia
[150]. The proliferation rates of these cilia-bearing cells is
lower compared to control tissue [150]. Furthermore, it
was shown that NPHP9 (NEK8), which is upregulated in
breast cancer [156], modulates cilia length and activates
the oncogenic Hippo pathway transcription factor TAZ
[157]. Melanoma development has several stages, ranging
from melanoma in situ, primary invasive melanoma and
metastatic melanoma. While melanocytes express primary
cilia, early melanoma in situ express hardly any cilia, and
cilia are completely lost in progressive tumor phases. In
this study, proliferation rates as determined by Ki67 stain-
ing were typically too low to account for the observed
reduction of cilia frequency [158]. Like melanoma, pancre-
atic ductal adenocarcinoma is also characterized by
activated Ras-signaling [158], and similarly reduced ciliary
frequencies were observed in early stages of tumor devel-
opment [41,159]. A loss of cilia was also observed in
ovarian cancer originating from the ovarian surface
epithelium that were growth arrested to normalize for the
effect of proliferation on cilia expression [160]. Another
study of an ovarian serous cystadenoma, based on
co-evolutionary analyses, identified an overrepresentation
of mutated cilia genes in this tissue [161]. On a more gen-
eral note, co-evolutionary analyses revealed that the cilia
proteome (ciliome) evolved concomitantly with multi-
cellularity and adopted important functions in the regula-
tion of cell-division control. Therefore, these authors
postulate by extrapolation that deregulation of the ciliary
network of proteins will result in proliferation in cancer
development [161]. We recently published data suggesting
a predisposition for tumor development in zebrafish that
carry a heterozygous mutation in cilia gene lrrc50 that also
causes PCD [162]. Tumors isolated from these zebrafish
are analogous to human seminoma, a subtype of
the group of testicular germ cell tumors (TGCT), and
germline loss-of-function mutations were identified in
human seminomas from patients with a family history of
seminoma formation. It is unclear, however, if mutant
LRRC50 tumor formation is attributable to impaired cilia
function but the mutations found in the seminomas
demonstrate cilia-associated gastrulation defects in fish
embryos [162]. Colorectal cancer is increasingly associatedwith a role for cilia. The cilia disassembly promoting
kinase Aurora A is often mutated in colorectal cancer
[163], as well as Hh member Gli3 and polycystic kidney
disease-causing ARPKD1 [164]. Elegant murine studies
have unraveled the role of cilia and crosstalk with the Hh-
signaling pathway in the development of skin tumors of
the basal cell carcinoma (BCC) subtype [165] and sub-
types of medulloblastoma brain tumors [166]. These stud-
ies collectively demonstrate in vivo that cilia can either
promote or repress tumor formation, but depletion of cilia
formation alone is not sufficient to drive tumor formation,
and tumor development requires driving oncogenic muta-
tion of Hh-components [167]. BCC, medulloblastoma and
other cancers, including pancreatic and ovarian cancers
described above, often upregulate Hh-signaling. In tumors
driven by upstream mutations in the Hh pathway (Ptc,
Smo, Sufu or excessive Hh-ligand), the cilium is required
to process GliA and activate downstream targets [151].
Intriguingly, in mutants driven by oncogenic Smo, simul-
taneous blocking of cilia formation by knocking out Kif3a
or Ift88, resulted in impaired GliA formation and inhib-
ition of tumorigenesis, suggesting that in this model,
tumor formation is cilia-dependent [165,166]. If tumor
formation is caused by mutations downstream of cilia
(Gli1A, Gli2A), cilia are obsolete for Hh activation. How-
ever, restored ciliation dampens Hh-signaling, which is
explained by the formation of Gli3R that counteracts GliA
[151]. Thus, selection for the presence or absence of cilia
of these cancer types entirely depends on the underlying
oncogenic mutation. Medulloblastomas featuring onco-
genic mutations in β-catenin also retain cilia, indicating
that cilia function is still required for tumor formation. Al-
though cilia generally reduce β-catenin nuclear-signaling,
which would place selective pressure for cilia-loss in
tumors, it is possible that a threshold level of Hh-signaling
is still required in some tumor types, leading to cilia reten-
tion [166]. On a more general note, tumors that depend
on cilia retention seem to have better prognosis with
regard to survival [166]. In addition to these cell-
autonomous Hh effects, increased Hh-signaling through
autocrine or paracrine signals from the tumor stroma adds
another layer of complexity [168].
Cilia loss is prevalent in various forms of kidney cancer.
Renal cysts are a hallmark phenotype of cilia dysfunction
and prevalent in many classic ciliopathy syndromes [49].
Accumulating evidence suggests that renal cystic lesions
are a precursor stage of tumor formation; patients with
acquired cystic kidney disease (ACKD) have an increased
risk for renal cancer with incidences ranging from 2 to 5%
[169]. It was recently demonstrated that chronic lithium
therapy (a standard therapy for bipolar disorder) increased
the risk for ACKD and kidney cancer development;
lithium activates GSK3β by phosphorylation, resulting in
increased β-catenin-signaling, which is known to suffice
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(RCC) can be subdivided into clear cell RCC (ccRCC),
chromophobe (chrRCC) and papillary RCC (pRCC) sub-
types [171,172]. Renal oncocytoma closely resembles the
chrRCC pathology [173,174], and both tumor types arise
from unciliated intercalated cells of the renal collecting
duct. Analysis of a small cohort of ccRCC indicated
severely reduced cilia frequencies and a more subtle
reduction in pRCC [175], our own results, in a large group
of ccRCC compared to parenchymal tissue confirmed this
and also indicated reduced frequencies in oncocytomas
and chrRCC [176]. Both studies excluded the possible
confounder that the fewer cilia observed were due to
increased cell proliferation through scoring for Ki67-
positive cells [175,176]. Intriguingly, cancer syndromes
that predispose to RCC development, encoded for by
mutant VHL, FLCN or TSC1/2 (discussed in greater detail
in a separate section), all have been shown to assert
molecular activity towards cilia function and structure in
addition to their previously recognized functions in relay-
ing responses to metabolic factors. This puts forward the
hypothesis that kidney cancer is a two-step process in
which both primary cilium function needs to be impaired
as well as modification of metabolic pathways; uncoupling
regulation by energy, nutrients, oxygen and iron. Of inter-
est, in a family predisposed to RCC and thyroid cancer, a
genomic breakpoint was identified disrupting TRC8, a
protein related to PTCH [177].
Familial cancer syndromes and cilia
Genetic predisposition to solid tumor development is
typically associated with heterozygous germline mutations
in tumor suppressor genes or oncogenes. Identifying the
genes and pathways mutated in these rare cancer
syndromes has been proven remarkably useful in under-
standing early events of tumor development. Because a
single patient with a germline mutation may have several
lesions of varying degrees, it is possible to understand the
genetic and cellular contribution to the natural course of
that particular tumor type. Functional aspects of many of
these genes have been elucidated, and interestingly, a
number of well- established classic tumor suppressor
proteins are involved in ciliary biogenesis, in addition to
their attributed functions. The fundamental processes
underlying cancer development and the tissues targeted in
these syndromes are likely to require modulation of
multiple cellular processes prior to carcinogenesis. Yet,
the association of several classic tumor suppressor
proteins and cilia suggests that ciliary loss, at least in some
tissues like perhaps the kidney, can be associated with very
early events in tumorigenesis.
For example, mutations in the VHL tumor suppressor
cause the autosomal dominant familial cancer syndrome
von Hippel-Lindau disease (VHL) that is characterized bythe development of renal and pancreatic cysts, ccRCC,
pheochromocytoma (tumor of the adrenal gland), cysts
and hemangiomas in the central nervous system, retinal
angiomas, and low-grade adenocarcinomas of the
temporal bone [178]. In addition, VHL is also inactivated
in up to 87% of sporadic clear cell RCC’s [179]. VHL loss
conforms to the Knudson 2-hit model that dictates that
both wild-type alleles of a tumor suppressor gene must be
inactivated prior to tumor outgrowth [180]. Depending on
the germline mutation resulting in complete loss-of-
function or missense hypomorphic mutations, the disease
is manifested in a subset or combination of target organs.
VHL’s biological activity is complex; one major role is the
degradation of HIF transcription factors, which become
stabilized in hypoxic conditions and regulate the activation
of a transcriptional program that promotes angiogenesis
[164]. Given that artificially high activity of HIFs is not
sufficient for RCC development [181], VHL must exert
alternative protein functions. HIF-independent functions
of VHL include regulation of cell polarity through Par3,
Par6 and stabilization and orientation of microtubules
[182]. Interestingly, VHL binds kinesin-2 subunits KIF3A
and KAP, and it facilitates renal cilia mechanosensation
[164]. Moreover, VHL seems to act in conjunction with
GSK3β to maintain cilia; depletion of either protein alone
does not affect ciliation, but activation of GSK3β in the
absence of VHL initiates cilia disassembly [183]. The
current view is that loss of VHL is sufficient for renal cyst
formation, but that additional genetic lesions are required
for subsequent degeneration of a renal cyst into ccRCC
[164,180]. The observation that mice with inactivated
Vhlh and Pten develop epididymal cystadenomas supports
this model [184]. The chance of acquiring additional
inactivating alleles at other loci is promoted by VHL loss,
given that loss of VHL also reduces Mad2 levels, a protein
that is part of the spindle checkpoint [185]. Aneuploidy
and chromosomal instability drive subsequent genetic
changes associated with RCC.
Tuberous sclerosis (TSC) is an autosomal dominant
disorder that associates with neurologic disorders such as
epilepsy, mental retardation and autism, but is mainly a
tumor suppressor gene syndrome associated with renal
cyst formation and tumorigenesis in various organs
including the kidney, brain, retina and skin [186,187]. TSC
is associated with germline mutations in TSC1/Harmatin
and TSC2/Tuburin [188]. Renal phenotypes in TSC
patients mostly comprise benign renal angiomyolipoma
(50 to 80%), but a minority develops ccRCC (3%) [169].
Although the overall ccRCC incidence is only marginally
increased compared to the general population, the onset
of ccRCC development in TSC patients seems to occur
earlier in life and other RCC pathologies are sometimes
also observed [187]. Mouse models similarly develop cysts
and RCC [189-191]. TSC disease manifestation requires
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TSC2, rendering it a classic tumor suppressor gene. In
contrast to VHL, loss of Tsc1 or Tsc2 enhances cilia length
in mouse MEF’s and zebrafish mutants [186,192], which
could explain why TSC patients clinically exhibit few renal
cysts and relatively low RCC frequency [188]. The
increased cilia length fits with the finding that disruption
of a number of neurologic disorder-associated genes simi-
larly enhance cilia length [54]. The mTOR pathway senses
nutrient and energy levels and regulates cell growth ac-
cordingly. TSC1 and TSC2 normally form a heterodimer
TSC1/2 that inhibits the TORC1 complex. Blocking the
mTORC1 complex using rapamycin reduces cilia length,
suggestive of a role for nutrient/energy-sensing in cilia
length control [193]. The TORC1 complex functions
upstream of the S6 kinase 1 (S6K1) which regulates ribo-
somal function and translation. Overexpression of s6k1 in
zebrafish also increases cilia length, making it likely that
the TORC1 complex regulates cilia length through S6K1.
Thus, loss of TSC1/2 releases the repression of TORC1,
activating S6K1 and increasing cilia length [193]. In
addition, GSK3β was found to function as an upstream
activator of TORC1 [193]. The emerging view thus
suggests that low energy/nutrient levels activates the
mTOR pathway and via S6K1 enhances cilia length, which
physically delays the cell cycle in a similar fashion to Nde1
and Tctex1 [140,141].
Functioning in the same nutrient/energy-sensing pathway
is FLCN, which is the gene product of the disease locus for
the monogenic disorder Birt-Hogg-Dubé (BHD) syndrome
[194]. BHD syndrome is characterized by the development
of renal cysts, kidney tumors of various histopathological
subtypes, pulmonary cysts and benign cutaneous tumors
(fibrofolliculomas) [195]. Renal tumors isolated from BHD
patients are histologically diverse, predominantly consisting
of chrRCC (34%) and hybrid oncocytoma/chromophobe
(50%) neoplasms (both derived from intercalated cells of
the collecting duct), and less frequently ccRCC (9%) [196].
Accordingly, mouse mutants for BHD-syndrome form
renal cysts and RCC [197]. We have shown that FLCN
levels affect ciliation [195,198]. In contrast to TSC1/2,
FLCN does not affect cilia length but rather regulates the
timing of ciliation. FLCN-associated cilia loss results in in-
creased β-catenin-signaling and loss of FLCN additionally-
induced PCP defects, which could explain the renal cystic
phenotype in BHD patients [195,198]. FLCN has further
been described to signal to AMPK, TSC1/2 and TORC1,
however there is conflicting data and it remains uncertain
whether FLCN activates or inhibits the mTOR pathway. In
mouse renal tumors, loss of FLCN activates TSC1/2 [199].
It has been suggested that inappropriately high as well as
low levels of TORC can lead to renal tumor formation
[200], however, the precise role of ciliary-signaling in these
events remains elusive.Another member of the energy/nutrient-sensing path-
way is the kinase LKB1, encoded for by STK11. Mutations
in STK11 predispose to the Peutz-Jeghers tumor syn-
drome (PJS) that features benign gastrointestinal (GI)
polyps as well as malignant tumors in the GI, breast and
gynecological organs. Somatic STK11mutations have been
identified in lung, bladder and cervical cancer [201]. LKB1
is a master regulator of numerous downstream kinases,
including AMPK and is upstream of mTOR-signaling
[201]. Simultaneous inactivation of lkb1 and vhl in
zebrafish, however, neutralizes AMPK activation and the
lkb1 phenotype, suggesting a complex interplay between
hypoxia and AMPK pathways [202]. The role of cilia in
LKB1 regulation is currently limited, however it has been
shown that cilia mechanosensation under flow conditions
requires ciliary-localized Lkb1 to activate AMPK and
mTOR-signaling to regulate cell size. This effect is inde-
pendent of Ca2+-mediated mechanosensation [203]. Simi-
lar to FLCN and VHL, LKB1 and IFT88 independently
regulate spindle positioning in epithelial cells [96,185,204].
Mosaic variegated aneuploidy syndrome (MVA) is a rare
autosomal recessive childhood cancer disorder character-
ized by mosaic aneuploidies that give rise to rhabdomyo-
sarcoma, Wilms’ tumor/polycystic nephroblastoma and
leukemia [205]. Associated pathologies overlap with the
ciliopathy disease spectrum; polycystic kidneys, micro-
cephaly, Dandy-Walker complex, intrauterine growth
retardation, mental retardation, infantile obesity, congeni-
tal abnormalities, eye abnormalities, postcerebellar cyst
and hypoplasia of the cerebellar vermis [206,207]. MVA
can be caused by biallelic as well as monoallelic mutations
in BUB1B and CEP57 [205]. BUB1B encodes for the
spindle checkpoint protein BUBR1, defects in which cause
premature chromosome segregation errors and neuploidy
in vitro [208]. A recently identified additional function for
BUBR1 is the regulation of ciliogenesis. Quiescence is
maintained through proteasomal degradation of a number
of substrates including DVL. Basal DVL activity is
required for basal body docking and ciliogenesis, however,
increased activity leads to downstream canonical Wnt-
activation and cell cycle progression. In control and MVA
patient-derived fibroblasts, BUBR1 was identified as an
essential co-activator of the APC/CCDC20 complex that
targets CDC20 for degradation and allows the APC/CCDH1
to maintain low DVL levels during quiescence through
proteasomal degradation. Consequently, high levels of
DVL in MVA-cells inhibit ciliogenesis. The inability of
BUBR1 to bind CDC20 and inhibit APC/CCDC20 also
disturbs the spindle assembly checkpoint and subsequent
faithful chromosome segregation [207].
Basal cell nevus syndrome or Gorlin syndrome is a
rare autosomal dominant disorder with an estimated
incidence of 1 in 57,000, and is characterized by a variable
disease spectrum including macrocephaly, frontal bossing,
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ition for BCC and medulloblastoma development [209].
Mutations have been identified in hedgehog components,
mostly located to PTCH1. Also, in sporadic BCC and
medulloblastoma, mutations in Hh-components, including
PTCH2, SUFU and SMO, have been demonstrated [210].
As described above, hedgehog-signaling is dependent on
intact cilia to appropriately process GliA and GliR.
One of the most frequently mutated genes in somatically
acquired colorectal cancer is the APC tumor suppressor
which, if mutated in the germline, causes familial adenoma-
tous polyposis (FAP). One subtype of FAP is Gardner’s
syndrome characterized by frequent extracolonic manifes-
tations such as osteomas, skin cysts, desmoid tumors and
retinal abnormalities [211]. This disease spectrum overlaps
with ciliopathy disease characteristics and suggests a role
for APC in cilia function. In addition, retrospective studies
noted that most patients with FAP display extracolonic
ciliopathy phenotypes of varying severity [211]. APC can
bind the kinesin-2 member Kif3a and microtubule binding
protein EB1, both essential for ciliation [212,213]. In
addition, APC interacts with EB1 and KIF17 and stabilizes
microtubule plus-ends [214].
In addition to the tumor suppressors in familial cancer
development described above, a number of additional
tumor suppressors and oncogenes, not directly associated
with familial cancer syndromes but often somatically mu-
tated in sporadic cancers, also can affect cilia biogenesis.
Members of the Wnt- and Hh-signaling pathway that have
somatically acquired oncogenic activity such as β-catenin,
Ptc, Smo, Sufu and Gli lead to aberrant transcription of
target genes, which is a constituent in many cancer types
[68]. The NEK family is composed of serine-threonine
kinases involved in cell cycle regulation and cancer forma-
tion. NEK1, NEK2 and NEK8/NPHP9 are related to ciliary
biogenesis [215,216]. Mouse models affecting either NEK1
or NEK8 protein function show phenotypic overlap with
ciliopathies [217,218]. Inactivation of NEK1 was recently
associated with the human ciliopathy autosomal-recessive
short-rib polydactyly syndrome [219]. Mutations in NEK1,
NEK2 and NEK8 have been identified in liver, ovarian, GI
and lung cancers [215]. Furthermore, NEK8/NPHP9 was
recently shown to directly bind the oncogenic transcrip-
tional activator TAZ [157], as was also reported for transi-
tion zone component NPHP4 [106]. These findings are
exciting since the Hippo pathway comprises a number of
proteins that act as a tumor suppressor network in the
control of organ size and growth control [105].
Chromosomal instability and cilia
The cell makes use of an elaborate and elegant system of
checkpoints to prevent and counteract cellular transform-
ation and cancerous outgrowth. These include the mitotic
or spindle checkpoint, as well as the DNA-damagecheckpoints. Failure of these control systems leads to an
accumulation of errors that eventually will result in
chromosomal instability, a major driver of cancer progres-
sion. With the exception of certain terminally differentiated
cell types, only one centrosome is present per quiescent
cell. Upon duplication in S-phase, centrosomes migrate to
opposing sides of the cell where they form spindle poles
during mitosis. Although cells are still able to successfully
segregate their chromosomes in the complete absence of
centrosomes, centrosomal abnormalities can have severe
effects on cells, ranging from defective spindle orientation,
ineffective asymmetric cell division and cancer. Defects in
centrosome separation or overreplication of centrosomes
drive aneuploidy [116]. Similarly, when cytokinesis is
perturbed, cells can inherit abnormal centrosome numbers.
In addition, cells inheriting multiple centrosomes will form
an equivalent number of cilia, which will distort signal
interpretation [220]. Centrosomal abnormalities are a
prominent feature of human tumors [220]. There are obvi-
ously many regulators of correct centrosome duplication
and cytokinesis; here we will only discuss the crossroads
between cilia biology and cancer development. Cilia defects
in the kidney often lead to cyst formation, and these cysts
can be considered benign neoplasms as they present hyper-
plasia; however, the incidence of tumor development in
patients with cystic ciliopathies is low, and a second event
is likely required for tumor growth initiation.
There is some emerging evidence that cilia defects can
be linked to mitotic abnormalities. Murine endothelial
cells derived from Pkd2 and Orpk/Ift88 knockout mice in
addition to cell samples derived from human ADPKD
patients had multipolar spindles and centrosomal abnor-
malities are observed that lead to polyploidy and chromo-
somal instability. Further analysis of these cells indicated
that the chromosomal passenger complex protein survivin
was down-regulated [221]. As discussed above, BUBR1
functions both in mitotic and ciliogenesis control [207],
and interestingly, another member of the spindle assembly
checkpoint, Mps1, has recently been shown to also affect
ciliogenesis [222]. In cycling cells, depletion of either
Mps1 or its direct interaction partner VDAC3 induces ab-
errant ciliogenesis, and upon serum starvation localization
of Mps1 to the centrosome is sufficient to suppress
ciliogenesis in RPE cells, suggesting it is a negative regula-
tor of ciliation [222]. It would be interesting to study other
components of the spindle checkpoint, such as the MAD
proteins, for putative roles in ciliogenesis. Several other
cell culture-based studies support a mechanism that could
explain the induction of centrosomal abnormalities in
cilia-related proteins; we previously reported that there is
a large proteomic overlap between ciliogenesis and cyto-
kinesis, including members of the chromosomal passenger
complex [126], indicating that defects in these proteins
can affect ciliogenesis as well as mitosis. As described in
Basten and Giles Cilia 2013, 2:6 Page 16 of 23
http://www.ciliajournal.com/content/2/1/6more detail above, oncogenic activation of HEF1 and
downstream Aurora A induce premature cilia resorption
and induce centrosomal over-replication [127]. Indeed,
disruption of several cilia-related genes stimulates
inappropriate cell cycle progression that can develop into
replication stress. The IFT motor kinesin-2 does not
exclusively function in cilia, but is also pivotal for normal
mitosis; mutant KIF3B induces aneuploidy and induces
multipolar spindle formation in NIH3T3 cells [223]. In
addition, the KIF3 complex functions as a tumor suppres-
sor in embryonic brain tumors, and Kap3−/− MEFs fail to
transport cadherin complexes to the membrane and to
inhibit downstream β-catenin activity [224].
The accumulation of DNA damage over time similarly
increases the risk of cell transformation and cancer
development. Cellular checkpoints normally prevent cells
from proliferation under these conditions; this is regulated
through the DNA damage response pathway, which is
largely mediated by ATM and ATR [225]. The centrosomal
proteins CEP152 and PCNT are required for ATR-
dependent DNA damage response-signaling. Mutations in
these genes lead to Seckel syndrome that is characterized
by dwarfism, microcephaly and mental retardation, pheno-
typically overlapping somewhat with the ciliopathy disease
spectrum [226]. Recently, we and others have shown that
mutations in SDCCAG8, ZNF423 and CEP164 cause a
NPHP-related ciliopathy and that these proteins localize to
both the centrosome and DNA damage foci, and are
required for proper DNA damage-induced response
[226,227]. CEP164 is a well known regulator of cilia forma-
tion and is one of the earliest proteins that defines a
matured centriole by the formation of distal appendages
[228]. In addition, we have seen that Cep164 loss not only
induces DNA damage response but also induces DNA
damage in the form of lagging anaphases, probably
resulting in mitotic catastrophe. Induced DNA damage by
irradiation causes premature centriole splitting [229]. The
resulting centriolar clusters sustain ciliogenesis, but upon
depletion of centriolar linker proteins C-NAP1 or rootletin,
ciliogenesis is perturbed [230]. It would be of interest to
further study the defective cilia/DNA damage response
crosstalk in light of cancer biology.
Metastasis
Cell migration occurs generally in early development,
wound-healing and chemotaxis. In aggressive cancers,
transformed cells detach from the primary tumor and
migrate throughout the body to form distant metastases.
Cell migration is a multi-step process that partially
depends on highly dynamic actin rearrangements, loss of
focal adhesions, lamellipodia formation and changes of
cell-matrix interaction [231]. In this light it is also of inter-
est that Aurora A activator HEF1 regulates focal adhesions
and is a prometastatic factor with elevated expression inmelanoma and glioblastomas [127]. Cilia regulate normal
cell migration in wound healing in response to the PDGF-
AA chemokine, and fibroblasts defective in primary cilia
fail to initiate chemotaxis [102]. It was observed that cilia
are often oriented towards the direction of migration,
suggesting that cilia provide context for directed cell mi-
gration [103]. Endothelial cells derived from the Ift88−/−
oak ridge polycystic kidney mouse model showed reduced
F-actin stress fibers, reduced focal adhesions and impaired
cell migration due to down-regulated Hsp27 and focal
adhesion kinase (FAK). Endothelial cells derived from
Pkd1 (PC1) deficient mice did not show these defects,
indicating that normal ciliation is involved in this process
[232]. Finally, in an RNA interference screen in MCF-10A
cells, NEK8 depletion was identified as a potent inducer of
induced cell migration [233]. There are however many
different signal transduction pathways that at various
levels contribute to cellular migration, such as cell-matrix
interactions, cell polarity and receptors dispersed across
the plasma membrane rather than being enriched in the
cilium. In the years to come, there will likely be an expan-
sion of our understanding of the role of cilia in cell migra-
tion, and hence how, and if, defects in ciliary-signaling
might affect cancer metastasis formation.
Conclusions/perspectives
Because of the tremendous efforts made to dissect ciliary
function, the level of data depth has now reached a point
where we can appreciate the subtle reality that the cilium
both taps into and cross-talks with many classical molecu-
lar signaling pathways, coordinating and fine-tuning cellular
responses. Cancer development is a multi-step process that
does not depend on one singular event, but is suggested
to require the sequestration of at least six capabilities
that allow survival and outgrowth. These include (1)
desensitization to anti-proliferative signals and (2) replica-
tive stress, (3) escape from apoptosis, (4) acquisition of
sustained angiogenesis and (5) metastasis potential and (6)
autonomous generation of proliferative signals. To achieve
this, cancer cells must promote chromosomal instability
followed by continuous trial-and-error before the required
capabilities have been acquired [234]. Therefore the
proclamation that tumorigenesis is a bona fide ciliopathy,
or whether the cilium is a bona fide tumor suppressor, can
be rejected, as neither of the two is correct. Depending on
the oncogenic event, cells will either select for cilia reten-
tion or disposal and are thus upstream or downstream
of cancer development. In Figure 5 we describe ways the
cilium might function in tumorigenesis. Most cells normally
establish a cilium and are able to interpret environmental
sensing such as contact signals or metabolic factors includ-
ing nutrient, oxygen and Ca2+ levels. Step 1: cilia are lost
and will result in a benign neoplasm with limited over-
proliferation and polarity defects. Step 2: environmental
Figure 5 Model of cilia and cancer. We propose a number of pathways that can lead to cilia-dependent and cilia-independent tumor
formation. The left pathway describes the oncogenic events that must follow after cilia have been lost (1) and a benign neoplasm has been
formed; accumulation of genetic lesions (2) that desensitize cells to the microenvironment or CIN (3) to drive further cancer progression.
Alternatively, the right pathway indicates a scenario where cilia are not involved in the initial transformation event (4). Depending on the
underlying oncogenic mechanism, cells will further develop into a cilia-independent cancer (5), or will select for cilia retention in cilia-dependent
cancer types (6).
Basten and Giles Cilia 2013, 2:6 Page 17 of 23
http://www.ciliajournal.com/content/2/1/6sensing is lost and cells transform. Step 3: cumulative DNA
damage and replicative stress induce chromosome instabil-
ity and lead to malignant cancer. Based on the clinical ob-
servation described above, the trend in most cancers seems
to be in accordance with steps 1 to 3. Step 4: alternatively,
cells transform but remain dependent on ciliary signaling.
Steps 5 and 6: these tumors can acquire chromosomal in-
stability and either dispose of (5), or retain (6), cilia to be-
come cancerous. Cataloging various tumor subtypes and
relating these to ciliation frequency scores might be an im-
portant next step in relation to future therapeutic ap-
proaches. Tumors that depend on cilia function, forexample Hh-mediated tumors, might benefit from comple-
mentary treatment with Aurora A activators which pro-
mote cilia disassembly and therefore dampen Hh-signaling,
or targeting downstream Hh transcription factors. Alterna-
tively, tumors that select for cilia disposal might benefit
from treatment with cilia-stabilizing molecules such as
low-dose taxol and HDAC-inhibitors. Low-dose paclitaxel
stabilizes microtubules and cilia and ameliorates renal
fibrosis in rats [235]. For extensive reviews on putative
therapeutic approaches we refer to excellent surveys by
Scales and de Sauvage [168] and Hassounah, Bunch
and McDermott [151]. Thus, although the cilium does not
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default, targeting its function could be a method to
switch cancer off.
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